Corbus Pharmaceuticals第二季度每股收益$（1.44）击败$（1.52）估计

Corbus Pharmaceuticals (NASDAQ: CRBP) reported quarterly losses of $(1.44) per share which beat the analyst consensus estimate of $(1.52) by 5.39 percent. This is a 60 percent decrease over losses of $(0.90) per share from the same period last year.